•
Sep 30, 2019

Bio-Rad Q3 2019 Earnings Report

Total Revenue
$561M
Previous year: $545M
+2.8%
EPS
$1.61
Previous year: $0.91
+76.9%
Gross Margin
54.8%
Operating Margin
10.2%
Gross Profit
$307M
Previous year: $287M
+7.1%
Cash and Equivalents
$561M
Previous year: $435M
+29.1%
Free Cash Flow
$68.7M
Previous year: $40.2M
+70.7%
Total Assets
$7.18B
Previous year: $6.72B
+6.8%

Bio-Rad

Bio-Rad

Bio-Rad Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income